This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sapiens (SPNS) Q4 Earnings Beat Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 2.78% and 1.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wesco International (WCC) Misses Q4 Earnings Estimates
by Zacks Equity Research
Wesco International (WCC) delivered earnings and revenue surprises of -1.86% and 1.52%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Salesforce, Qualcomm, Verint, Varonis and S&P Global
by Zacks Equity Research
Salesforce, Qualcomm, Verint, Varonis and S&P Global are included in this Analyst Blog.
Here is Why Growth Investors Should Buy Salesforce.com (CRM) Now
by Zacks Equity Research
Salesforce.com (CRM) could produce exceptional returns because of its solid growth attributes.
Salesforce Ascends 33% in Six Months: Is the Stock Still a Buy?
by Anirudha Bhagat
CRM's market leadership, aggressive AI expansion and increasing enterprise IT spending trends create a solid foundation for sustained growth.
AI Marketing at Super Bowl 2025: Will Pricey Ads Pay Off?
by Rimmi Singhi
Companies are going all in on AI ads at Super Bowl 2025. OpenAI, GOOGL, GDDY, META, BKNG and CRM are spending $8M per ad. Will it be worth it?
5 Big Data Providers to Buy on Lucrative Short-Term Upside Potential
by Nalak Das
Five Big Data stocks have strong revenue and earnings growth potential for 2025. These are: CRM, QCOM, VRNT, VRNS, SPGI.
Pros Holdings (PRO) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Pros Holdings (PRO) delivered earnings and revenue surprises of 23.08% and 0.21%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Salesforce.com (CRM) Laps the Stock Market: Here's Why
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $344.14, moving +1.44% from the previous trading session.
Wall Street Bulls Look Optimistic About Salesforce.com (CRM): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BlackBerry Completes Sale of Cylance Endpoint to Arctic Wolf
by Zacks Equity Research
BB sells its Cylance endpoint security assets to Arctic Wolf for $160 million in cash and equity.
Is Trending Stock Salesforce Inc. (CRM) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
AI Winners Following the DeepSeek Disruption
by Neena Mishra
We highlight ETF areas that could benefit if AI costs decline.
Here's Why Salesforce.com (CRM) Fell More Than Broader Market
by Zacks Equity Research
Salesforce.com (CRM) closed at $354 in the latest trading session, marking a -1.65% move from the prior day.
Strength Seen in Salesforce.com (CRM): Can Its 4.0% Jump Turn into More Strength?
by Zacks Equity Research
Salesforce.com (CRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why Salesforce.com (CRM) Gained But Lagged the Market Today
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $326.84, indicating a +0.7% shift from the previous trading day.
Here's Why Investors Should Buy EPAM Systems Stock Right Now
by Zacks Equity Research
EPAM is rapidly expanding in the emerging AI space through partnerships and acquisitions, making it a promising player for 2025 and beyond.
Does a P/E Multiple of 6.67X Make Pitney Bowes a Strong Buy?
by Subham Roy
PBI stock presents an attractive investment opportunity, driven by its robust financial recovery, undervalued valuation and optimistic growth prospects.
The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences
by Zacks Equity Research
Salesforce, Shell and Gilead Sciences are included in this Analyst Blog.
Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc (SHEL) and Gilead Sciences, Inc. (GILD).
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Salesforce.com (CRM) closed at $323.54 in the latest trading session, marking a +1.4% move from the prior day.
UiPath Stock's 6-Month Consolidation: A Potential Buying Opportunity?
by Shuvra Shankar Dey
With PATH stock consolidating for six months, we assess its current status to decide on the best strategy for the future.